Valneva SE (VALN) Depreciation & Amortization - Total (2022 - 2026)

Valneva SE (VALN) posted Depreciation & Amortization - Total of $4.9 million for Q1 2026, down 1.76% sequentially from $5.0 million in Q4 2025, and up 11.3% YoY from $4.4 million in Q1 2025.

Valneva SE (VALN) Depreciation & Amortization - Total (2022 - 2026) Analysis & Trends

Valneva SE has reported Depreciation & Amortization - Total for 5 years, with the latest figure at $4.9 million in Q1 2026.

  • Quarterly Depreciation & Amortization - Total rose 11.3% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 18.53% YoY) and the FY2025 annual result came in at $19.7 million, up 23.64% from the prior year.
  • Depreciation & Amortization - Total eased to $4.9 million in Q1 2026 per VALN's latest filing, from $5.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization - Total peaked at $10.7 billion in Q3 2022 and troughed at -$10.8 billion in Q4 2022.
  • A 5-year average of -$4.5 million and a median of $4.1 million in 2024 frame the typical range for Depreciation & Amortization - Total.
  • The widest YoY moves for Depreciation & Amortization - Total: up 100.03% in 2023, down 99.97% in 2023.
  • Over 5 years, Depreciation & Amortization - Total stood at -$10.8 billion in 2022, then soared by 100.03% to $3.7 million in 2023, then advanced by 16.84% to $4.3 million in 2024, then increased by 17.1% to $5.0 million in 2025, then fell by 1.76% to $4.9 million in 2026.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $4.9 million, $5.0 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Valneva SE 618.67 Mn 477.41 Mn 1.86 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4.92 Mn
Dec 31, 2025 5.01 Mn
Sep 30, 2025 4.91 Mn
Jun 30, 2025 4.75 Mn
Mar 31, 2025 4.42 Mn
Dec 31, 2024 4.27 Mn
Sep 30, 2024 4.06 Mn
Jun 30, 2024 3.77 Mn
Mar 31, 2024 3.80 Mn
Dec 31, 2023 3.66 Mn
Sep 30, 2023 3.27 Mn
Jun 30, 2023 3.05 Mn
Mar 31, 2023 2.79 Mn
Dec 31, 2022 -10.78 Bn
Sep 30, 2022 10.66 Bn